CANN
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
4.35M
CGC
Price
$1.37
Change
-$0.05 (-3.52%)
Updated
Sep 25 closing price
Capitalization
432.79M
42 days until earnings call
Interact to see
Advertisement

CANN vs CGC

Header iconCANN vs CGC Comparison
Open Charts CANN vs CGCBanner chart's image
TREES
Price$0.04
Change-$0.00 (-0.00%)
Volume$57.93K
Capitalization4.35M
Canopy Growth
Price$1.37
Change-$0.05 (-3.52%)
Volume$12.1M
Capitalization432.79M
CANN vs CGC Comparison Chart in %
Loading...
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANN vs. CGC commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANN is a Hold and CGC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CANN: $0.04 vs. CGC: $1.37)
Brand notoriety: CANN: Not notable vs. CGC: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CANN: 27% vs. CGC: 55%
Market capitalization -- CANN: $4.35M vs. CGC: $432.79M
CANN [@Pharmaceuticals: Generic] is valued at $4.35M. CGC’s [@Pharmaceuticals: Generic] market capitalization is $432.79M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANN’s FA Score shows that 0 FA rating(s) are green whileCGC’s FA Score has 0 green FA rating(s).

  • CANN’s FA Score: 0 green, 5 red.
  • CGC’s FA Score: 0 green, 5 red.
According to our system of comparison, CANN is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANN’s TA Score shows that 4 TA indicator(s) are bullish while CGC’s TA Score has 4 bullish TA indicator(s).

  • CANN’s TA Score: 4 bullish, 5 bearish.
  • CGC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CANN and CGC are a bad buy in the short-term.

Price Growth

CANN (@Pharmaceuticals: Generic) experienced а -1.23% price change this week, while CGC (@Pharmaceuticals: Generic) price change was -0.72% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Reported Earning Dates

CGC is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($433M) has a higher market cap than CANN($4.35M). CANN YTD gains are higher at: 122.222 vs. CGC (-50.000). CANN has higher annual earnings (EBITDA): 619K vs. CGC (-410.31M). CGC has more cash in the bank: 144M vs. CANN (245K). CANN has less debt than CGC: CANN (17.4M) vs CGC (328M). CGC has higher revenues than CANN: CGC (275M) vs CANN (14.5M).
CANNCGCCANN / CGC
Capitalization4.35M433M1%
EBITDA619K-410.31M-0%
Gain YTD122.222-50.000-244%
P/E RatioN/AN/A-
Revenue14.5M275M5%
Total Cash245K144M0%
Total Debt17.4M328M5%
FUNDAMENTALS RATINGS
CANN vs CGC: Fundamental Ratings
CANN
CGC
OUTLOOK RATING
1..100
2466
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3855
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CANN's Valuation (67) in the null industry is in the same range as CGC (92) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

CANN's Profit vs Risk Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

CGC's SMR Rating (99) in the Agricultural Commodities Or Milling industry is in the same range as CANN (100) in the null industry. This means that CGC’s stock grew similarly to CANN’s over the last 12 months.

CANN's Price Growth Rating (38) in the null industry is in the same range as CGC (55) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

CANN's P/E Growth Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CANNCGC
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRSCX22.05N/A
N/A
Carillon Eagle Small Cap Growth A
CFIGX14.63N/A
N/A
Columbia Flexible Capital Income C
WSCJX15.34N/A
N/A
Allspring Disciplined Small Cap R6
FEURX49.61N/A
N/A
First Eagle Gold R6
FAPHX13.53N/A
N/A
Fidelity Healthy Future

CANN and

Correlation & Price change

A.I.dvisor tells us that CANN and MEDIF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANN and MEDIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANN
1D Price
Change %
CANN100%
-2.68%
MEDIF - CANN
22%
Poorly correlated
+2.45%
SFOSF - CANN
21%
Poorly correlated
N/A
CGC - CANN
20%
Poorly correlated
-3.52%
CNTMF - CANN
14%
Poorly correlated
N/A
CAIHF - CANN
12%
Poorly correlated
N/A
More